India's Strides Arcolab gets FDA nod for two HIV/AIDS new drug applications (Sharewatch)
MUMBAI (Thomson Financial) - India's Strides Arcolab Ltd said it has received tentative approvals from the US Food and Drug Administration for two new drug applications for fixed-dose combination of Lamivudine/Stavudine in HIV/AIDS treatment segment.

Indian biotech to witness more mergers, acquisitions: experts (PharmaBiz)
India is being viewed as a destination for partnerships and mergers. In the next two years, large and medium size biotech companies across the world would look to partner, merge and acquire some of their Asian counterparts and India is the strongest contender.

International Movement Disorder Specialists Receive New Information About The Use Of Once-Daily AZILECT(R) In The ... (Medical News Today)
New information on the use of AZILECT(R) (rasagiline tablets) for the treatment of Parkinson's disease (PD) was reported this week at The Movement Disorder Society's congress in Istanbul, Turkey. Once-daily AZILECT was approved by the FDA May 17, 2006, for the treatment of the signs and symptoms of PD, both as initial monotherapy and as adjunct therapy to levodopa. [click link for full article]